Celadon Pharmaceuticals Plc (AIM:CEL)
London
· Delayed Price · Currency is GBP · Price in GBX 4.500
+0.500 (11.11%)
May 9, 2025, 4:35 PM GMT+1
Celadon Pharmaceuticals Market Cap
Celadon Pharmaceuticals has a market cap or net worth of 3.10 million as of May 9, 2025. Its market cap has decreased by -95.29% in one year.
Market Cap
3.10M
Enterprise Value
7.88M
Revenue
130.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.50
Market Cap Chart
Since March 29, 2022, Celadon Pharmaceuticals's market cap has decreased from 89.42M to 3.10M, a decrease of -96.54%. That is a compound annual growth rate of -66.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3.10M | -70.00% |
| Dec 31, 2024 | 10.33M | -86.01% |
| Dec 29, 2023 | 73.84M | 137.10% |
| Dec 30, 2022 | 31.14M | -65.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.39B |